Conference: Gene Therapy for Rare Disorders, 2022
Precision will be at this year’s Gene Therapy for Rare Disorders from March 7 – 10th in Boston. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the clinical development, manufacturing, and commercialization of therapies for rare genetic disorders.
White Paper: Considerations for the Clinical Development of Cell & Gene Therapies (Part 2: Gene Therapies)
Advances in stem cell technology, combined with the increasing prevalence of chronic diseases, are driving rapid growth in the regenerative medicine category, which is predicted to generate $39.33 billion in revenue by 2023.
White Paper: Considerations for the Clinical Development of Cell & Gene Therapies (Part 1: Cell Therapies)
The regenerative medicine category is predicted to generate $39.33 billion in revenue by 2023, with the fastest growth expected in cell therapy.
Article: Mind the Skills Gap
“There’s a little over 1,200 clinical trials worldwide, and about half of those are in the US. Over 100 of those are in phase III, so we’re getting really close to getting more approved.”
